Startseite>>Natural Products>>Demethylwedelolactone

Demethylwedelolactone (Synonyms: DWL, Norwedelolactone, 1,3,8,9-Tetrahydroxycoumestan)

Katalog-Nr.GC38576

Demethylwedelolacton ist ein natÜrlich vorkommendes Coumestan, das aus Eclipta alba isoliert wird. Demethylwedelolacton ist ein potenter Trypsin-Inhibitor mit einem IC50 von 3,0 μM. Demethylwedelolacton unterdrÜckt die ZellmotilitÄt und die Zellinvasion von Brustkrebszellen.

Products are for research use only. Not for human use. We do not sell to patients.

Demethylwedelolactone Chemische Struktur

Cas No.: 6468-55-9

Größe Preis Lagerbestand Menge
1mg
48,00 $
Auf Lager
5mg
144,00 $
Auf Lager
10mg
234,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com

Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Demethylwedelolactone is a naturally occurring coumestan isolated from Eclipta alba. Demethylwedelolactone is a potent trypsin inhibitor with an IC50 of 3.0 μM. Demethylwedelolactone suppresses cell motility and cell invasion of breast cancer cell[1][2].

[1]. Syed SD, et al. Trypsin inhibitory effect of wedelolactone and demethylwedelolactone. Phytother Res. 2003 Apr;17(4):420-1. [2]. Lee YJ, et al. Demethylwedelolactone derivatives inhibit invasive growth in vitro and lung metastasis of MDA-MB-231 breast cancer cells in nude mice. Eur J Med Chem. 2012 Oct;56:361-7.

Bewertungen

Review for Demethylwedelolactone

Average Rating: 5 ★★★★★ (Based on Reviews and 12 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Demethylwedelolactone

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.